A Personal Decision Support System for Heart Failure Management (HeartMan): study protocol of the HeartMan randomized controlled trial
Authors:
- Anneleen BaertABAnneleen Baert
- Els ClaysECEls Clays
- Larissa BolligerLBLarissa Bolliger
- Delphine De SmedtDSDelphine De Smedt
- Mitja LustrekMitja Lustrek
- Aljoša VodopijaAVAljoša Vodopija
- Marko BohanecMBMarko Bohanec
- Paolo Emilio PudduPaolo Emilio Puddu
- Maria Costanza CiancarelliMCMaria Costanza Ciancarelli
- Michele SchiaritiMSMichele Schiariti
- Jan DerbovenJDJan Derboven
- Gennaro TartariscoGennaro Tartarisco
Open Access
- 27 September 2018
- journal article
- research article
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 18 (1) , 1-9
Abstract
Heart failure (HF) is a highly prevalent chronic disease, for which there is no cure available. Therefore, improving disease management is crucial, with mobile health (mHealth) being a promising technology. The aim of the HeartMan study is to evaluate the effect of a personal mHealth system on top of standard care on disease management and health-related quality of life (HRQoL) in HF. HeartMan is a randomized controlled 1:2 (control:intervention) proof-of-concept trial, which will enrol 120 stable ambulatory HF patients with reduced ejection fraction across two European countries. Participants in the intervention group are equipped with a multi-monitoring health platform with the HeartMan wristband sensor as the main component. HeartMan provides guidance through a decision support system on four domains of disease management (exercise, nutrition, medication adherence and mental support), adapted to the patient’s medical and psychological profile. The primary endpoint of the study is improvement in self-care and HRQoL after a six-months intervention. Secondary endpoints are the effects of HeartMan on: behavioural outcomes, illness perception, clinical outcomes and mental state. HeartMan is technologically the most innovative HF self-management support system to date. This trial will provide evidence whether modern mHealth technology, when used to its full extent, can improve HRQoL in HF. This trial has been registered on https://clinicaltrials.gov/ct2/show/NCT03497871 , on April 13 2018 with registration number NCT03497871.Keywords
Funding Information
- Horizon 2020 Framework Programme (689660)
This publication has 27 references indexed in Scilit:
- Mind–body practices: An alternative, drug-free treatment for smoking cessation? A systematic review of the literatureDrug and Alcohol Dependence, 2013
- Epidemiology of Heart FailureCirculation Research, 2013
- Factors Related to Morbidity and Mortality in Patients With Chronic Heart Failure With Systolic DysfunctionCirculation: Heart Failure, 2012
- Impact of Remote Telemedical Management on Mortality and Hospitalizations in Ambulatory Patients With Chronic Heart FailureCirculation, 2011
- Telemonitoring in Patients with Heart FailureNew England Journal of Medicine, 2010
- Peer-facilitated cognitive dissonance versus healthy weight eating disorders prevention: A randomized comparisonBody Image, 2010
- Cardiac rehabilitation in Europe: results from the European Cardiac Rehabilitation Inventory SurveyEuropean Journal of Preventive Cardiology, 2010
- The Support, Education, and Research in Chronic Heart Failure Study (SEARCH): A mindfulness-based psychoeducational intervention improves depression and clinical symptoms in patients with chronic heart failureAmerican Heart Journal, 2009
- Clinical epidemiology of heart failureHeart, 2007
- The Brief Illness Perception QuestionnaireJournal of Psychosomatic Research, 2006